Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes

Liposomal amphotericin B (AmB) or AmBisome(®) is the most effective and safe therapeutic agent for visceral leishmaniasis (VL), but its clinical efficacy is limited in cutaneous leishmaniasis (CL) and HIV/VL co-infection. The aim of this work was to develop a formulation of AmB in PEGylated liposome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Guilherme S., Vallejos, Virgínia M. R., Borges, Gabriel S. M., Almeida, Raquel M., Alves, Izabela M., Aguiar, Marta M. G., Fernandes, Christian, Guimarães, Pedro P. G., Fujiwara, Ricardo T., Loiseau, Philippe M., Ferreira, Lucas A. M., Frézard, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147047/
https://www.ncbi.nlm.nih.gov/pubmed/35631575
http://dx.doi.org/10.3390/pharmaceutics14050989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147047/
https://www.ncbi.nlm.nih.gov/pubmed/35631575
http://dx.doi.org/10.3390/pharmaceutics14050989

Ejemplares similares